Read + Share
Amedeo Smart
Independent Medical Education
Chen W, Shi J, Luo Y, Yu J, et al. Selective histone deacetylase inhibitor after allo-HCT for T-cell acute lymphoblastic leukemia or T-cell lymphoma. Bone Marrow Transplant 2024 Jan 23. doi: 10.1038/s41409-023-02191.PMID: 38263392
Email
LinkedIn
Facebook
Twitter
Privacy Policy